Work

Indacaterol/glycopyrronium (IND/GLY) reduces exacerbation and improves lung function versus salmeterol/fluticasone (SFC) in patients with and without prior ICS use: The FLAME study

Year: 2016

Type: conference-abstract

Source: European Respiratory Journal

DOI: 10.1183/13993003.congress-2016.pa987

Authors: Francesco Patalano, Jadwiga A. Wedzicha, Jørgen Vestbo, Angel FowlerTaylor, Tim Ayers, Chau Thach, Neha Ruparelia, Robert Fogel, Donald Banerji

Institutions: Novartis (Switzerland), Imperial College London, University of Manchester, Novartis (United States)

Language: English

Topic: Chronic Obstructive Pulmonary Disease (COPD) Research

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2550623081

Cites:

Cited by:

Related to: 10